Tesamorelin Dosage Guide & Research Calculator
This tesamorelin dosage guide covers reconstitution math, an embedded concentration calculator, and dose ranges for tesamorelin reported in published preclinical and clinical research literature. All figures below summarize parameters reported in published preclinical or in-vitro research. They are provided for reference only and are not instructions for human or veterinary administration.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.
Tesamorelin reconstitution math & tesamorelin dosage calculator
Reconstituting a lyophilized peptide gives a solution with a known concentration. The formula is simple:
Worked example: Adding 2 mL of bacteriostatic water to a 10 mg vial of tesamorelin yields 5,000 mcg/mL. 0.20 mL (20 units on a U-100 insulin syringe) of that solution represents 1,000 mcg (1 mg) of peptide.
Enter your values
The total mass of lyophilized powder listed on the vial label.
The volume of bacteriostatic water added to the vial.
The amount, in micrograms, to model in your concentration math (1 mg = 1,000 mcg).
Display volume in U-100 syringe units or plain mL.
Based on your inputs
This tool performs unit conversion and concentration math for research planning. It is not medical advice, not a dose recommendation, and not intended for human or veterinary use.
Tesamorelin doses reported in published preclinical research
The figures below summarize Tesamorelin doses that appear in published animal-model or in-vitro studies. They describe what researchers have used in laboratory settings — they are not human administration protocols and are not dose recommendations.
| Research context | Dose reported | Notes |
|---|---|---|
| Published clinical trials, daily SC | 1 mg/day | Lower dose arm reported in published studies. |
| Published clinical trials, daily SC | 2 mg/day | Higher dose arm reported in published studies. |
| Preclinical rodent studies | 10–100 µg/kg/day | Subcutaneous ranges in animal-model literature. |
All values are research-context references compiled from published preclinical and in-vitro literature. Tesamorelin is supplied for laboratory and research use only.
Continue your Tesamorelin research
Tesamorelin research dosage — frequently asked questions
How is tesamorelin reconstituted for research?+
Lyophilized tesamorelin is dissolved in bacteriostatic water. Concentration is calculated as (vial mg × 1000) ÷ diluent mL, giving mcg per mL.
What concentration does 10 mg tesamorelin in 2 mL give?+
10 mg in 2 mL of bacteriostatic water yields a 5,000 mcg/mL solution. 0.20 mL (20 units on a U-100 insulin syringe) contains 1,000 mcg (1 mg).
What tesamorelin doses are reported in published research?+
Published clinical trials most commonly reference 1 mg/day and 2 mg/day subcutaneous study arms; preclinical animal-model studies report ranges in the 10–100 µg/kg/day region.
Is this tesamorelin dosage guide for human use?+
No. Tesamorelin is supplied for laboratory and research use only. The figures above are research-context references and are not human administration instructions.
For laboratory and research use only. Not for human or veterinary use. The information below summarizes dosing parameters reported in published research and is provided for reference only — not as guidance for administration.